Senate Finance Committee Issues Testimony From Civica
June 03, 2020
June 03, 2020
WASHINGTON, June 3 -- The Senate Finance Committee issued the following testimony by Martin VanTrieste, president and CEO of Civica Inc., at a hearing entitled "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" on June 2:
My name is Martin VanTrieste. I am the President and CEO of Civica, Inc. I am also a 35-year veteran of the pharmaceutical industry.
It is an honor to appear before you today, and an honor to follow a . . .
My name is Martin VanTrieste. I am the President and CEO of Civica, Inc. I am also a 35-year veteran of the pharmaceutical industry.
It is an honor to appear before you today, and an honor to follow a . . .